Literature DB >> 19815001

Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction.

Gary Aston-Jones1, Rachel J Smith, Gregory C Sartor, David E Moorman, Lema Massi, Pouya Tahsili-Fahadan, Kimberlei A Richardson.   

Abstract

Orexins (synonymous with hypocretins) are recently discovered neuropeptides made exclusively in hypothalamus. Behavioral, anatomical, and neurophysiological studies show that a subset of these cells, specifically those in lateral hypothalamus (LH), are involved in reward processing and addictive behaviors. Fos expression in LH orexin neurons varied in proportion to conditioned place preference (CPP) for morphine, cocaine, or food. This relationship occurred both in drug-naïve rats and in animals during protracted morphine withdrawal, when drug preference was elevated but food preference was decreased. Inputs to the LH orexin cell field from lateral septum and bed nucleus of the stria terminalis were Fos-activated during cocaine CPP in proportion to the preference expressed in each animal. This implies that these inputs may be involved in driving the conditioned responses in LH orexin neurons. Related studies showed that LH orexin neurons that project to ventral tegmental area (VTA) had greater Fos induction in association with elevated morphine preference during protracted withdrawal than non-VTA-projecting orexin neurons, indicating that the VTA is an important site of action for orexin's role in reward processing. In addition, stimulation of LH orexin neurons, or microinjection of orexin into VTA, reinstated an extinguished morphine preference. In self-administration studies, the orexin 1 receptor antagonist SB-334867 (SB) blocked cocaine-seeking induced by discrete or contextual cues previously associated with cocaine, but not by a priming injection of cocaine. There was no effect of SB on cocaine self-administration itself, indicating that it did not interfere with the drug's reinforcing properties. Neurophysiological studies revealed that locally applied orexin often augmented responses of VTA dopamine (DA) neurons to activation of the medial prefrontal cortex (mPFC), consistent with the view that orexin facilitates activation of VTA DA neurons by stimulus-reward associations. This LH-to-VTA orexin pathway was found to be necessary for learning a morphine place preference. These findings are consistent with results showing that orexin facilitates glutamate-mediated responses, and is necessary for glutamate-dependent long-term potentiation in VTA DA neurons. We surmise from these studies that LH orexin neurons play an important role in reward processing and addiction and that LH orexin cells are an important input to VTA for behavioral effects associated with reward-paired stimuli. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815001      PMCID: PMC2819557          DOI: 10.1016/j.brainres.2009.09.106

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  141 in total

1.  Insular hypocretin transmission regulates nicotine reward.

Authors:  Jonathan A Hollander; Qun Lu; Michael D Cameron; Theodore M Kamenecka; Paul J Kenny
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

2.  Distinct sites of opiate reward and aversion within the midbrain identified using a herpes simplex virus vector expressing GluR1.

Authors:  W A Carlezon; C N Haile; R Coppersmith; Y Hayashi; R Malinow; R L Neve; E J Nestler
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

3.  Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons.

Authors:  D B Carr; S R Sesack
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

4.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

5.  Hypocretin/orexin depolarizes and decreases potassium conductance in locus coeruleus neurons.

Authors:  A Ivanov; G Aston-Jones
Journal:  Neuroreport       Date:  2000-06-05       Impact factor: 1.837

6.  Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system.

Authors:  T L Horvath; C Peyron; S Diano; A Ivanov; G Aston-Jones; T S Kilduff; A N van Den Pol
Journal:  J Comp Neurol       Date:  1999-12-13       Impact factor: 3.215

7.  Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell.

Authors:  Ruth Sharf; Maysa Sarhan; Ralph J Dileone
Journal:  Biol Psychiatry       Date:  2008-04-18       Impact factor: 13.382

8.  Hypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons.

Authors:  Nicole M Vittoz; Brooke Schmeichel; Craig W Berridge
Journal:  Eur J Neurosci       Date:  2008-10       Impact factor: 3.386

Review 9.  Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence.

Authors:  Rachel J Smith; Gary Aston-Jones
Journal:  Brain Struct Funct       Date:  2008-07-24       Impact factor: 3.270

10.  Cocaine serves as a peripheral interoceptive conditioned stimulus for central glutamate and dopamine release.

Authors:  Roy A Wise; Bin Wang; Zhi-Bing You
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

View more
  145 in total

Review 1.  Circadian rhythms and mood regulation: insights from pre-clinical models.

Authors:  Colleen A McClung
Journal:  Eur Neuropsychopharmacol       Date:  2011-08-11       Impact factor: 4.600

2.  Antagonism of orexin 1 receptors eliminates motor hyperactivity and improves homing response acquisition in juvenile rats exposed to alcohol during early postnatal period.

Authors:  Georg M Stettner; Leszek Kubin; Denys V Volgin
Journal:  Behav Brain Res       Date:  2011-03-21       Impact factor: 3.332

Review 3.  Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity.

Authors:  Angie M Cason; Rachel J Smith; Pouya Tahsili-Fahadan; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Physiol Behav       Date:  2010-03-23

Review 4.  Central GLP-1 receptors: Novel molecular targets for cocaine use disorder.

Authors:  N S Hernandez; H D Schmidt
Journal:  Physiol Behav       Date:  2019-03-28

5.  Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system.

Authors:  Marsida Kallupi; Nazzareno Cannella; Daina Economidou; Massimo Ubaldi; Barbara Ruggeri; Friedbert Weiss; Maurizio Massi; Juan Marugan; Markus Heilig; Patricia Bonnavion; Luis de Lecea; Roberto Ciccocioppo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

6.  Hyperactive hypothalamus, motivated and non-distractible chronic overeating in ADAR2 transgenic mice.

Authors:  A Akubuiro; M Bridget Zimmerman; L L Boles Ponto; S A Walsh; J Sunderland; L McCormick; M Singh
Journal:  Genes Brain Behav       Date:  2013-02-18       Impact factor: 3.449

7.  Role of orexin/hypocretin in conditioned sucrose-seeking in rats.

Authors:  Angie M Cason; Gary Aston-Jones
Journal:  Psychopharmacology (Berl)       Date:  2012-10-25       Impact factor: 4.530

8.  The lateral hypothalamus to lateral habenula projection, but not the ventral pallidum to lateral habenula projection, regulates voluntary ethanol consumption.

Authors:  Chandni Sheth; Teri M Furlong; Kristen A Keefe; Sharif A Taha
Journal:  Behav Brain Res       Date:  2017-04-19       Impact factor: 3.332

Review 9.  Therapeutics development for addiction: Orexin-1 receptor antagonists.

Authors:  David A Perrey; Yanan Zhang
Journal:  Brain Res       Date:  2018-08-24       Impact factor: 3.252

Review 10.  Neurobiological studies of fatigue.

Authors:  Mary E Harrington
Journal:  Prog Neurobiol       Date:  2012-07-24       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.